Sard Wealth Management Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Buy
1,520
+35
+2% +$8.15K 0.2% 41
2025
Q4
$307K Buy
1,485
+67
+5% +$13.2K 0.17% 44
2025
Q3
$263K Buy
1,418
+16
+1% +$2.74K 0.15% 46
2025
Q2
$214K Sell
1,402
-52
-4% -$7.99K 0.13% 45
2025
Q1
$241K Sell
1,454
-52
-3% -$8.14K 0.16% 41
2024
Q4
$218K Sell
1,506
-34
-2% -$5.27K 0.15% 43
2024
Q3
$250K Sell
1,540
-2
-0.1% -$319 0.16% 38
2024
Q2
$225K Sell
1,542
-114
-7% -$17K 0.16% 39
2024
Q1
$262K Sell
1,656
-54
-3% -$8.6K 0.24% 35
2023
Q4
$268K Buy
+1,710
New +$262K 0.27% 34

Other funds holding JNJ

Sard Wealth Management Group's JNJ Position: Q1 2026 in Review

Sard Wealth Management Group increased its Johnson & Johnson (JNJ) stake by 2.4% in Q1 2026, buying an estimated $8.15K and bringing the position to 1,520 shares worth $372K. The position accounts for 0.2% of the portfolio, ranked #41.

Sard Wealth Management Group first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sard Wealth Management Group held 1,520 shares of Johnson & Johnson worth $372K as of Q1 2026.
  • Sard Wealth Management Group bought 35 Johnson & Johnson shares in Q1 2026, an estimated $8.15K.
  • Johnson & Johnson made up 0.2% of Sard Wealth Management Group's portfolio in Q1 2026, its #41 holding.
  • Sard Wealth Management Group first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sard Wealth Management Group's 13F filing for Q1 2026, filed 10 Apr 2026.